Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innovative technologies for the fabrication of 3D/4D smart hydrogels and its biomedical applications - A comprehensive review.
Shashikumar U, Saraswat A, Deshmukh K, Hussain CM, Chandra P, Tsai PC, Huang PC, Chen YH, Ke LY, Lin YC, Chawla S, Ponnusamy VK. Shashikumar U, et al. Among authors: deshmukh k. Adv Colloid Interface Sci. 2024 May 7;328:103163. doi: 10.1016/j.cis.2024.103163. Online ahead of print. Adv Colloid Interface Sci. 2024. PMID: 38749384 Review.
Conventional and frugal methods of estimating COVID-19-related excess deaths and undercount factors.
Dedhe AM, Chowkase AA, Gogate NV, Kshirsagar MM, Naphade R, Naphade A, Kulkarni P, Naik M, Dharm A, Raste S, Patankar S, Jogdeo CM, Sathe A, Kulkarni S, Bapat V, Joshi R, Deshmukh K, Lele S, Manke-Miller KJ, Cantlon JF, Pandit PS. Dedhe AM, et al. Among authors: deshmukh k. Sci Rep. 2024 May 6;14(1):10378. doi: 10.1038/s41598-024-57634-6. Sci Rep. 2024. PMID: 38710715 Free PMC article.
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial.
Bennett C, Woo W, Bloch M, Cheung K, Griffin P, Mohan R, Deshmukh S, Arya M, Cumming O, Neville AM, McCallum Pardey TG, Plested JS, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Marcheschi A, Swan J, Smith G, Cho I, Glenn GM, Walker R, Mallory RM; Novavax 2019nCoV-311 Study Group. Bennett C, et al. Lancet Infect Dis. 2024 Mar 6:S1473-3099(24)00077-X. doi: 10.1016/S1473-3099(24)00077-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38460525
111 results